DOULEUR
-Donovan A. Argueta, Christopher M. Ventura, Stacy Kiven, Varun Sagi, and Kalpna Gupta
A Balanced Approach for Cannabidiol Use in Chronic Pain, 2020
-Xantus, G., Zavori, L., Matheson, C., Gyarmathy, V. A., Fazekas, L. M., & Kanizsai, P. (2021). Cannabidiol in low back pain: scientific rationale for clinical trials in low back pain.Expert Review of Clinical Pharmacology, 14(6), 671-675.
-Burr, J. F., Cheung, C. P., Kasper, A. M., Gillham, S. H., & Close, G. L. (2021). Cannabis and athletic performance.Sports Medicine, 1-13.
-Mohan, H., Romano, R., Andersen, A., Vera, E., Iwasaka-Neder, J., Kajita, A., … & Miyake, M. M. (2022). Efficacy of Cannabidiol Versus Ibuprofen in the Relief of Menstrual Pain in Females Living with Primary Dysmenorrhea: A phase II, Non-Inferiority trial.Principles and Practice of Clinical Research,8(3), 68-76.
-Li, X., Vigil, J. M., Stith, S. S., Brockelman, F., Keeling, K., & Hall, B. (2019). The effectiveness of self-directed medical cannabis treatment for pain.Complementary Therapies in Medicine,46, 123-130 Baswan, S. M., Klosner, A. E., Glynn, K., Rajgopal, A., Malik, K., Yim, S., & Stern, N. (20
– Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors, 2012
Wei Xiong,Tanxing Cui, Kejun Cheng, Fei Yang, Shao-Rui Chen, Dan Willenbring, Yun Guan, Hui-Lin Pan, Ke Ren, Yan Xu, and Li Zhang
STRESS/SOMMEIL
-Cannabidiol in Anxiety and Sleep: A Large Case Series, 2019
Scott Shannon, MD, Nicole Lewis, ND,Heather Lee, PA-C, and Shannon Hughes.
-Sholler, D. J., Schoene, L., & Spindle, T. R. (2020). Therapeutic efficacy of cannabidiol (CBD): a review of the evidence from clinical trials and human laboratory studies.Current addiction reports,7, 405-412.
-Shannon, S., Lewis, N., Lee, H., & Hughes, S. (2019). Cannabidiol in anxiety and sleep: a large case series.The Permanente Journal,23.
-Kuhathasan, N.; Dufort, A.; Mackillop, J.; Gottschalk, R. et al. (2019). The use of cannabinoids for sleep: A critical review on clinical trials. Exp Clin Psychopharmacol, 27, n. 4, p. 383-401, Août 2019.
-Moltke, J. & Hindocha, C. (2021). Gründe für den Konsum von Cannabidiol: Eine Querschnittsstudie von CBD-Konsumenten, die sich auf selbst wahrgenommenen Stress, Angstzustände und Schlafprobleme konzentriert.
– Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients, 2011
Mateus M Bergamaschi, Regina Helena Costa Queiroz, Marcos Hortes Nisihara Chagas, Danielle Chaves Gomes de Oliveira, Bruno Spinosa De Martinis, Flávio Kapczinski, João Quevedo, Rafael Roesler, Nadja Schröder, Antonio E Nardi, Rocio Martín-Santos, Jaime Eduardo Cecílio Hallak, Antonio Waldo Zuardi, and José Alexandre S Crippa
NEURO
– Review of the neurological benefits of phytocannabinoids, 2018
Joseph Maroon and Jeff Bost
– Thiele, E. et al. (2018). Cannabidiol bei Patienten mit Krampfanfällen im Zusammenhang mit dem Lennox-Gastaut-Syndrom (GWPCARE4): eine randomisierte, doppelblinde, placebokontrollierte Phase-3-Studie.
– Szaflarski, J. (2018). Cannabidiol verbessert die Häufigkeit und Schwere von Anfällen und reduziert unerwünschte Ereignisse in einer offenen prospektiven Zusatzstudie. Epilepsie & Verhalten. Seiten 131-136.
– Cannabinoids and Pain: New Insights From Old Molecules, 2018
Sonja Vučković, Dragana Srebro, Katarina Savić Vujović, Čedomir Vučetić and Milica Prostran
SOIN PEAU
-Baswan, S. M., Klosner, A. E., Glynn, K., Rajgopal, A., Malik, K., Yim, S., & Stern, N. (2020). Therapeutic potential of cannabidiol (CBD) for skin health and disorders.Clinical, cosmetic and investigational dermatology, 927-942.
-Chelliah, M. P., Zinn, Z., Khuu, P., & Teng, J. M. (2018). Self‐initiated use of topical cannabidiol oil for epidermolysis bullosa.Pediatric dermatology,35(4), e224-e227
– A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars, 2019
B Palmieri , C Laurino , M Vadalà